Lucia Gallego Manzano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lucia Gallego Manzano has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Fabrizio Murtas
CERN, 1211 Geneva, Switzerland
2 shared publications - Marco Silari
CERN, European Organization for Nuclear Research, Genève, Switzerland
2 shared publications - Albert J. J. M. van Breemen
TNO at Holst Centre High Tech Campus 31 Eindhoven 5656 AE The Netherlands
1 shared publication - Alejandro Ribagorda Alfaro
Advanced Oncotherapy plc, in A.D.A.M. S.A., Rue de Veyrot 11, 1217 Meyrin, Switzerland
1 shared publication - Alessandro Zimmaro
European Organization for Nuclear Research (CERN), Geneva, Switzerland
1 shared publication Alexander Gotschy
Department of Cardiology, University Heart Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland; Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105869
Updating national diagnostic reference levels for adult cardiac interventional procedures in Switzerland
- 30 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105869
Open AccessUpdating national diagnostic reference levels for adult cardiac interventional procedures in Switzerland
- Open Access
- 25 June 2026
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 46 (3) , 031514
Impact of the ICRU/ICRP proposal on operational quantities during interventional procedures: Investigation through spectral measurements
In low-energy photon fields, such as those encountered during fluoroscopy-guided interventions, the current operational quantity for area dosimetry, ambient dose equivalent H*(10), overestimates effective dose by roughly a factor of two. ICRU Report 95 introduces a revised set of operational quantities intended to better align with protection quantities, replacing H*(10) with ambient dose H* for area monitoring. Experimental data validating these changes in realistic clinical environments remain scarce. This study examines the differences between current and newly proposed operational quantities in scattered radiation fields representative of occupational staff exposure during fluoroscopy-guided procedures. Measurements were performed using a Timepix4 hybrid pixel detector operated simultaneously as an X-ray spectrometer and dosimeter. The detector provides energy-resolved photon fluence measurements convertible into operational dose quantities via published fluence-to-dose conversion coefficients. Measurement campaigns were conducted in a urology theatre and an interventional cardiology (IC) theatre under realistic clinical conditions. Photon spectra were recorded at staff positions representative of standard procedures and converted into current and newly proposed quantities relevant to whole-body, skin, and eye lens exposure. The influence of beam angulation and additional shielding was further investigated in the IC theatre.For whole-body exposure, ratios between H* and H*(10) ranged from 0.52 in urology to 0.59 in IC. Quantities relevant to skin and eye lens exposure remained close to unity, with deviations not exceeding 5% and 8%, respectively. Beam angulation and shielding induced only minor variations in these ratios, below 5%.These results provide the first experimental validation of ICRU Report 95 quantities in interventional workplaces. Whole-body dosimetry is most affected by the transition, while skin and eye lens monitoring should remain largely unchanged. Ambient dosimeters calibrated in H*(10) used in low-energy photon fields may be recalibrated using a single procedure-specific calibration factor, whereas calibration procedures for skin and eye lens dosimeters may remain unchanged.
- 25 June 2026
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 46 (3) , 031514
Open AccessImpact of the ICRU/ICRP proposal on operational quantities during interventional procedures: Investigation through spectral measurements
In low-energy photon fields, such as those encountered during fluoroscopy-guided interventions, the current operational quantity for area dosimetry, ambient dose equivalent H*(10), overestimates effective dose by roughly a factor of two. ICRU Report 95 introduces a revised set of operational quantities intended to better align with protection quantities, replacing H*(10) with ambient dose H* for area monitoring. Experimental data validating these changes in realistic clinical environments remain scarce. This study examines the differences between current and newly proposed operational quantities in scattered radiation fields representative of occupational staff exposure during fluoroscopy-guided procedures. Measurements were performed using a Timepix4 hybrid pixel detector operated simultaneously as an X-ray spectrometer and dosimeter. The detector provides energy-resolved photon fluence measurements convertible into operational dose quantities via published fluence-to-dose conversion coefficients. Measurement campaigns were conducted in a urology theatre and an interventional cardiology (IC) theatre under realistic clinical conditions. Photon spectra were recorded at staff positions representative of standard procedures and converted into current and newly proposed quantities relevant to whole-body, skin, and eye lens exposure. The influence of beam angulation and additional shielding was further investigated in the IC theatre.For whole-body exposure, ratios between H* and H*(10) ranged from 0.52 in urology to 0.59 in IC. Quantities relevant to skin and eye lens exposure remained close to unity, with deviations not exceeding 5% and 8%, respectively. Beam angulation and shielding induced only minor variations in these ratios, below 5%.These results provide the first experimental validation of ICRU Report 95 quantities in interventional workplaces. Whole-body dosimetry is most affected by the transition, while skin and eye lens monitoring should remain largely unchanged. Ambient dosimeters calibrated in H*(10) used in low-energy photon fields may be recalibrated using a single procedure-specific calibration factor, whereas calibration procedures for skin and eye lens dosimeters may remain unchanged.
- 1 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Optimization of a single-phase liquid xenon Compton camera for 3γ medical imaging
Optimisation d'une camera Compton au xénon liquide à simple phase pour l'imagerie médicale 3γ: Les travaux décrits dans cette thèse sont centrés sur la caractérisation et l’optimisation d’une camera Compton à phase unique au xénon liquide pour des applications médicales. Le détecteur a été conçu pour exploiter les avantages d’une technique d’imagerie médicale innovante appelée l’imagerie 3γ. Elle vise à l’obtention de la position en 3D d’une source radioactive avec une très haute sensibilité et une réduction importante de la dose administrée au patient. L’imagerie 3γ est basée sur la détection en coïncidence de 3 photons gamma émis par un émetteur spécifique (+β, γ), le 44Sc. Un premier prototype de camera Compton au xénon liquide a été développé par le laboratoire Subatech à travers le projet XEMIS (Xenon Medical Imaging System), pour démontrer la faisabilité de l’imagerie 3γ. Ce nouveau système de détection comporte un système de cryogénie avancé et une électronique front-end à très faible bruit qui fonctionne à la température du xénon liquide. Ce travail a contribué à la caractérisation de la réponse du détecteur et à l’optimisation de la mesure du signal d’ionisation. L'influence de la grille de Frisch sur le signal mesuré a été particulièrement étudiée. Les premières preuves de la reconstruction Compton en utilisant une source de ²²Na (β+, Eγ = 1.274 MeV) sont aussi rapportées dans cette thèse et valident la preuve de concept de la faisabilité de l’imagerie 3γ. Les résultats présentés dans cette thèse ont joué un rôle essentiel dans le développement d’une camera Compton au xénon liquide de grandes dimensions pour l’imagerie des petits animaux. Ce nouveau détecteur, appelée XEMIS2, est maintenant en phase de construction.
- 1 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Optimization of a single-phase liquid xenon Compton camera for 3γ medical imaging
Optimisation d'une camera Compton au xénon liquide à simple phase pour l'imagerie médicale 3γ: Les travaux décrits dans cette thèse sont centrés sur la caractérisation et l’optimisation d’une camera Compton à phase unique au xénon liquide pour des applications médicales. Le détecteur a été conçu pour exploiter les avantages d’une technique d’imagerie médicale innovante appelée l’imagerie 3γ. Elle vise à l’obtention de la position en 3D d’une source radioactive avec une très haute sensibilité et une réduction importante de la dose administrée au patient. L’imagerie 3γ est basée sur la détection en coïncidence de 3 photons gamma émis par un émetteur spécifique (+β, γ), le 44Sc. Un premier prototype de camera Compton au xénon liquide a été développé par le laboratoire Subatech à travers le projet XEMIS (Xenon Medical Imaging System), pour démontrer la faisabilité de l’imagerie 3γ. Ce nouveau système de détection comporte un système de cryogénie avancé et une électronique front-end à très faible bruit qui fonctionne à la température du xénon liquide. Ce travail a contribué à la caractérisation de la réponse du détecteur et à l’optimisation de la mesure du signal d’ionisation. L'influence de la grille de Frisch sur le signal mesuré a été particulièrement étudiée. Les premières preuves de la reconstruction Compton en utilisant une source de ²²Na (β+, Eγ = 1.274 MeV) sont aussi rapportées dans cette thèse et valident la preuve de concept de la faisabilité de l’imagerie 3γ. Les résultats présentés dans cette thèse ont joué un rôle essentiel dans le développement d’une camera Compton au xénon liquide de grandes dimensions pour l’imagerie des petits animaux. Ce nouveau détecteur, appelée XEMIS2, est maintenant en phase de construction.
- Open Access
- 11 March 2023
- Published by Wiley in Medical Physics
- Vol. 50 (5) , 2844-2859
Clinical commissioning of the first point‐of‐care spectral photon‐counting CT for the upper extremities
Background: Acceptance testing and quality assurance (QA) of computed tomography (CT) scans are of great importance to ensure the appropriate performance of the systems. However, current standards and guidelines do not include a dedicated QA program for spectral photon‐counting CT (SPCCT), nor adapted tolerance levels.Purpose: To evaluate the technical performance, in terms of image quality and radiation dose, of the first point‐of‐care SPCCT for the upper extremities (MARS Extremity 5X120, MARS Bioimaging Ltd., Christchurch, New Zealand) and to establish a comprehensive QA program.Methods: The specific dimensions of the scanner with a 125 mm diameter gantry and a small voxel size of 0.1 × 0.1 × 0.1 mm3 require the use of suitable phantoms and evaluation techniques. Indicators such as CT number accuracy, image noise, uniformity, and slice thickness were assessed to characterize the image quality. The in‐plane and longitudinal spatial resolutions were evaluated by means of the modulation transfer function (MTF). Noise power spectra (NPS) were calculated to further evaluate the image noise. Material identification capabilities were assessed using clinically relevant high‐Z materials (iodine, gold, gadolinium, and calcium). A 100‐mm diameter CTDI‐like phantom was used to measure the dose indices. A complete radiation survey was carried out to measure the radiation exposure at different points around the scanner.Results: The proposed QA program is based on international and local recommendations as well as practical experience. It includes standardised CT tests and SPCCT‐specific methods. Additional methodologies to further assess the system performance are also presented. Tolerance levels are discussed and revised when appropriate. Both in‐plane and longitudinal high spatial resolutions were evidenced by the MTF measurements with 1.8 lp· mm−1 and 5.0 lp· mm−1 at 10%, respectively. The calculated effective slice thickness ranged between 0.15 and 0.16 mm for the five energy bins and for a reconstructed voxel size of 0.1 × 0.1 × 0.1 mm3. Reference values of the linear attenuation coefficient of water have been calculated and used to assess the CT number uniformity of water. Evaluation of the CT number accuracy and stability of various clinically relevant materials showed excellent spectral correlation and linearity between HU values and concentrations (r2 > 0.99). The NPS showed less noise correlation between slices than within transverse slice, as well as a systematic increase at low spatial frequencies. The volume CT dose index (CTDI) for a custom‐made 100 mm diameter phantom was 9.32 mGy. Radiation measurements around the scanner showed that it is completely shielded except for the access port, and that no additional protective measures are necessary for the patient.Conclusions: A routine QA framework for SPCCT systems has been proposed. Image quality and radiation dose were assessed using newly designed phantoms, relevant metrics, and automated algorithms. Baseline values were established and tolerance levels discussed for the MARS SPCCT scanner based on collected data and international recommendations.
- 11 March 2023
- Published by Wiley in Medical Physics
- Vol. 50 (5) , 2844-2859
Open AccessClinical commissioning of the first point‐of‐care spectral photon‐counting CT for the upper extremities
Background: Acceptance testing and quality assurance (QA) of computed tomography (CT) scans are of great importance to ensure the appropriate performance of the systems. However, current standards and guidelines do not include a dedicated QA program for spectral photon‐counting CT (SPCCT), nor adapted tolerance levels.Purpose: To evaluate the technical performance, in terms of image quality and radiation dose, of the first point‐of‐care SPCCT for the upper extremities (MARS Extremity 5X120, MARS Bioimaging Ltd., Christchurch, New Zealand) and to establish a comprehensive QA program.Methods: The specific dimensions of the scanner with a 125 mm diameter gantry and a small voxel size of 0.1 × 0.1 × 0.1 mm3 require the use of suitable phantoms and evaluation techniques. Indicators such as CT number accuracy, image noise, uniformity, and slice thickness were assessed to characterize the image quality. The in‐plane and longitudinal spatial resolutions were evaluated by means of the modulation transfer function (MTF). Noise power spectra (NPS) were calculated to further evaluate the image noise. Material identification capabilities were assessed using clinically relevant high‐Z materials (iodine, gold, gadolinium, and calcium). A 100‐mm diameter CTDI‐like phantom was used to measure the dose indices. A complete radiation survey was carried out to measure the radiation exposure at different points around the scanner.Results: The proposed QA program is based on international and local recommendations as well as practical experience. It includes standardised CT tests and SPCCT‐specific methods. Additional methodologies to further assess the system performance are also presented. Tolerance levels are discussed and revised when appropriate. Both in‐plane and longitudinal high spatial resolutions were evidenced by the MTF measurements with 1.8 lp· mm−1 and 5.0 lp· mm−1 at 10%, respectively. The calculated effective slice thickness ranged between 0.15 and 0.16 mm for the five energy bins and for a reconstructed voxel size of 0.1 × 0.1 × 0.1 mm3. Reference values of the linear attenuation coefficient of water have been calculated and used to assess the CT number uniformity of water. Evaluation of the CT number accuracy and stability of various clinically relevant materials showed excellent spectral correlation and linearity between HU values and concentrations (r2 > 0.99). The NPS showed less noise correlation between slices than within transverse slice, as well as a systematic increase at low spatial frequencies. The volume CT dose index (CTDI) for a custom‐made 100 mm diameter phantom was 9.32 mGy. Radiation measurements around the scanner showed that it is completely shielded except for the access port, and that no additional protective measures are necessary for the patient.Conclusions: A routine QA framework for SPCCT systems has been proposed. Image quality and radiation dose were assessed using newly designed phantoms, relevant metrics, and automated algorithms. Baseline values were established and tolerance levels discussed for the MARS SPCCT scanner based on collected data and international recommendations.
- 1 September 2021
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1010
Characterization of stilbene and EJ-276 scintillators coupled with a large area SiPM array for a fast neutron dose rate detector
- 1 September 2021
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1010
Characterization of stilbene and EJ-276 scintillators coupled with a large area SiPM array for a fast neutron dose rate detector
- Open Access
- 13 July 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (14) , 6459
Characterization with X-rays of a Large-Area GEMPix Detector with Optical Readout for QA in Hadron Therapy
Quality Assurance (QA) in hadron therapy is crucial to ensure safe and accurate dose delivery to patients. This can be achieved with fast, reliable and high-resolution detectors. In this paper, we present a novel solution that combines a triple Gas Electron Multiplier (GEM) and a highly pixelated readout based on a matrix of organic photodiodes fabricated on top of an oxide-based thin-film transistor backplane. The first LaGEMPix prototype with an active area of 60 × 80 mm2 was developed and characterized using low energy X-rays. The detector comprises a drift gap of 3.5 mm, a triple-GEM stack for electron amplification, and a readout featuring 480 × 640 pixels at a 126 µm pitch. Here, we describe the measurements and results in terms of spatial resolution for various experimental configurations. A comparison with GAFCHROMIC® films and the GEMPix detector used in the charge readout mode was performed to better understand the contribution to the spatial resolution from both the electron diffusion and the isotropic emission of photons. The measurements were compared to Monte Carlo simulations, using the FLUKA code. The simulation predictions are in good agreement with the GEMPix results. Future plans with respect to applications in hadron therapy are discussed.
- 13 July 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (14) , 6459
Open AccessCharacterization with X-rays of a Large-Area GEMPix Detector with Optical Readout for QA in Hadron Therapy
Quality Assurance (QA) in hadron therapy is crucial to ensure safe and accurate dose delivery to patients. This can be achieved with fast, reliable and high-resolution detectors. In this paper, we present a novel solution that combines a triple Gas Electron Multiplier (GEM) and a highly pixelated readout based on a matrix of organic photodiodes fabricated on top of an oxide-based thin-film transistor backplane. The first LaGEMPix prototype with an active area of 60 × 80 mm2 was developed and characterized using low energy X-rays. The detector comprises a drift gap of 3.5 mm, a triple-GEM stack for electron amplification, and a readout featuring 480 × 640 pixels at a 126 µm pitch. Here, we describe the measurements and results in terms of spatial resolution for various experimental configurations. A comparison with GAFCHROMIC® films and the GEMPix detector used in the charge readout mode was performed to better understand the contribution to the spatial resolution from both the electron diffusion and the isotropic emission of photons. The measurements were compared to Monte Carlo simulations, using the FLUKA code. The simulation predictions are in good agreement with the GEMPix results. Future plans with respect to applications in hadron therapy are discussed.
- Open Access
- 16 June 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Instrumentation and Measurement
- Vol. 70 (00189456) , 1-12
An IoT LoRaWAN Network for Environmental Radiation Monitoring
A reliable and highly scalable Internet of Things (IoT) end-to-end data infrastructure has been developed for environmental radiation monitoring at CERN based on a Low-Power Wide-Area Network (LPWAN). The proposed system,called W-MON (Waste radiation MONitoring), consists of an interconnected network of thousands of highly sensitive and ultra-low power gamma radiation sensors acting as LoRa transceivers. The aim of the system is to improve and automatize the radiological controls of conventional waste containers. The end-devices measure the radiation levels in the waste containers on a continuous basis and send the data periodically to the LoRaWAN network server. The network has been deployed in an outdoor environment covering hundreds of hectares. A set of web-based user applications for real-time monitoring, data visualization and status control of the devices have been designed based on open source tools. The data pipeline infrastructure has been designed to allow an easy integration into REMUS, the overall CERN Radiation and Environment Monitoring Unified Supervision service.
- 16 June 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Instrumentation and Measurement
- Vol. 70 (00189456) , 1-12
Open AccessAn IoT LoRaWAN Network for Environmental Radiation Monitoring
A reliable and highly scalable Internet of Things (IoT) end-to-end data infrastructure has been developed for environmental radiation monitoring at CERN based on a Low-Power Wide-Area Network (LPWAN). The proposed system,called W-MON (Waste radiation MONitoring), consists of an interconnected network of thousands of highly sensitive and ultra-low power gamma radiation sensors acting as LoRa transceivers. The aim of the system is to improve and automatize the radiological controls of conventional waste containers. The end-devices measure the radiation levels in the waste containers on a continuous basis and send the data periodically to the LoRaWAN network server. The network has been deployed in an outdoor environment covering hundreds of hectares. A set of web-based user applications for real-time monitoring, data visualization and status control of the devices have been designed based on open source tools. The data pipeline infrastructure has been designed to allow an easy integration into REMUS, the overall CERN Radiation and Environment Monitoring Unified Supervision service.